What is AARD (AARD) stock price today?

AARD (AARD) is currently trading at $6.42, down 4.04% today.

What is AARD P/E ratio?

AARD's P/E ratio is -1.62. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is AARD return on equity (ROE)?

AARD's return on equity (ROE) is -54.21%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is AARD's market cap?

AARD has a market capitalization of $140.50M.

NASDAQ · Biotechnology

AARD (AARD) Stock

$6.42 -4.04% NASDAQ: AARD Healthcare

Valuation

Metric	Value
Price	$6.42
Market Cap	$140.50M
P/E Ratio	-1.62
P/B Ratio	0.87
P/S Ratio	0.00
EPS (TTM)	$-2.64
52-Week High	$17.94
52-Week Low	$3.35
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-54.21%
ROA	-49.57%
ROCE	-59.43%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	10.18

Annual Financials (USD)

Metric	2022	2023	2024	2025
Revenue	$0	$0	$0	$0
Operating Profit	$-11.0M	$-7.0M	$-23.0M	$-63.0M
Net Profit	$-14.0M	$-7.0M	$-21.0M	$-58.0M
EPS	$-0.63	$-0.34	$-0.95	$-2.64
Op Margin	—	—	—	—

Balance Sheet (USD)

Metric	2022	2023	2024	2025
Total Assets	$17.0M	$11.0M	$78.0M	$117.0M
Total Liabilities	$45.0M	$45.0M	$132.0M	$11.0M
Cash	$16.0M	$10.0M	$62.0M	$47.0M
Borrowings	$0	$0	$1.0M	$0

Latest News

Several Insiders Invested In Aardvark Therapeutics Flagging Positive News Simply Wall St. · May 28, 2026 Sector Update: Healthcare Stocks Decline Late Afternoon MT Newswires · May 15, 2026 Top Midday Decliners MT Newswires · May 15, 2026 Sector Update: Healthcare Stocks Softer Friday Afternoon MT Newswires · May 15, 2026 Sector Update: Healthcare MT Newswires · May 15, 2026

Cash Flow (USD)

Metric	2022	2023	2024	2025
Operating Cash Flow	$-11.0M	$-6.0M	$-18.0M	$-54.0M
Investing Cash Flow	$-1.0M	$0	$-12.0M	$-50.0M
Financing Cash Flow	$1.0M	$0	$-3.0M	$0
Net Cash Flow	$-11.0M	$-6.0M	$52.0M	$-15.0M
Free Cash Flow	$-11.0M	$-6.0M	$-18.0M	$-54.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-65.98%
Quick Ratio	8.06
Interest Coverage	—
Return 1Y	-48.31%
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ASMB	$26.68	+0.87%	-51.53	$424.02M	0.00%
AVTX	$18.97	+2.87%	-2.79	$214.25M	0.00%
CRBU	$1.65	+0.61%	-1.25	$163.65M	0.00%
ENTA	$12.61	-0.94%	-6.04	$366.68M	0.00%
EPRX	$6.05	+4.13%	-5.99	$202.55M	0.00%

About AARD

AARD is led by CEO Tien-Li Lee, employs 22 people, headquartered in US, publicly traded since 2025.

AARD stock trades at $6.42 with a market capitalization of $140.50M. The stock is valued at a price-to-earnings (P/E) ratio of -1.62, price-to-book of 0.87, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.35 and $17.94, and currently trades 64.2% below its 52-week high.

On profitability, AARD generates a return on equity (ROE) of -54.21%, return on capital employed of -59.43%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides